Recombinant Human PLVAP Protein，His

PLVAP (Plasmalemma Vesicle Associated Protein) is a key protein involved in the regulation of endothelial permeability and is primarily expressed in the blood vessels, particularly in the microvascular endothelium. Its expression is crucial for maintaining the integrity of the blood-brain barrier and other tissue-specific barriers. Research into PLVAP has gained momentum due to its potential implications in various pathophysiological conditions, such as inflammation, tumor metastasis, and vascular diseases. Studies have shown that PLVAP plays a significant role in transcytosis and vesicular trafficking processes, impacting the movement of molecules and cells across endothelial barriers. The recombinant production of PLVAP has become an important focus to better understand its structural and functional properties. By employing advanced recombinant DNA technology, researchers can generate high-purity PLVAP proteins, facilitating in-depth studies on their biochemical characteristics and interactions with other cellular components. Furthermore, investigating PLVAP in a recombinant form allows for the development of targeted therapeutic strategies aimed at modulating vascular permeability in diseases associated with dysregulated endothelial function. Overall, the study of recombinant PLVAP not only enhances our understanding of its role in vascular biology but also opens avenues for novel therapeutic interventions in diseases characterized by altered endothelial permeability.